Your LCRF Winter e-news is here!
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌       


Winter 2022

Science News | Get Involved | Patient Journey

Joint paper makes recommendations on clinical trials in light of pandemic
"Impact of the COVID-19 Pandemic on Global Lung Cancer Clinical Trials: Why it matters to people with Lung Cancer" was accepted and published in the Journal of Thoracic Oncology Clinical and Research Reports. The article is a joint project of the Lung Cancer Research Foundation and several other organizations, and recommends actions that can be implemented long-term to increase access to clinical trials and remove barriers.
Annual ACS report shows progress in lung cancer survival rates
The American Cancer Society just released its annual Cancer Facts and Figures, and it included good news about lung cancer: more lung cancer is being detected early, and that's contributing to the increasing survival rates for patients. Visit our website to learn more and download the report.
FDA approves seven lung cancer treatments in 2021
The momentum continues for new findings leading to FDA-approved lung cancer treatments. In 2021, the FDA announced seven approvals; in the new year, Teliso-V was granted FDA Breakthrough Designation. Learn which drugs are newly available, along with the companion diagnostics.
Study focuses on Female Asian Never Smokers (FANS)
More than half of Asian American women diagnosed with lung cancer have never smoked. Professors Scarlett Lin Gomez, PhD, MPH, and Iona Cheng, PhD, MPH spoke with LCRF about the FANS (Female Asian Never Smokers) Study, which investigates possible causes of lung cancer, including secondhand smoke, genetics, and cultural factors.
Lung cancer & older adults
This month, we welcomed Dr. Carolyn Presley as our guest speaker for a #TogetherSeparately webinar on Treating Lung Cancer in Older Adults. Dr. Presley is a thoracic and geriatric oncologist and serves as co-director of the Cancer and Aging Resiliency Clinic at Ohio State University Comprehensive Cancer Center.
February webinar on COVID-19
Dr. Isabel Preeshagul and Dr. Jia Luo will lead an important discussion about Covid-19 and lung cancer. Get and update on how it affects people with lung cancer, keeping yourself and your loved ones safe, managing symptoms, and what to consider when seeking lung cancer treatment. Join us at 12 PM ET on Feb. 16.
Newest Team LCRF athletes getting ready to run a half marathon for research
Six dedicated supporters will be running the United Airlines NYC Half on March 20 and fundraising for lung cancer research! All of them support the cause in honor or memory of someone special. Learn who inspires them, and find out how you can help.
Your chance to bike for research
On May 1, cyclists will roll through every borough of New York City on streets free of cars. And Team LCRF will be there! If you'd like to be part of the ride, let us know at
Event dates coming soon!
Our 2022 event schedule is in progress, and we're planning at least a few in-person events – with safety in this ever-changing world as a top priority. We'll continue to host opportunities to bring the lung cancer community together online as well. Watch our website for announcements and details!
Patient grateful for 'little magic pill'
In 2018, Rhonda was diagnosed with Stage IV non-small cell adenocarcinoma, with metastasis to her brain, spine, hip bone, and lymph nodes. Her biopsy confirmed she had the EGFR mutation, and she began taking osimertinib. "Medicine has significantly advanced, and people are living much longer and with fewer complications than ever," she said.
...everyone who donated on #GivingTuesday and through the end of 2021 – because of you, 2022 is a year filled with hope.
...Frank McKenna, who lent his eloquent words to our efforts to thank our donors and fundraisers.




LCRF logo

Donate | Unsubscribe | View E-News Online

Lung Cancer Research Foundation, 501 7th Ave, Suite 401, New York, NY 10018 | | ©2022

powered by Blackbaud
nonprofit software